C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2006
12/05/2006	US7144991 Use of fusion proteins, especially scFvSA, as diagnostic markers or as cell specific targeting agents.
12/05/2006	US7144990 Antibody to a polypeptide overexpressed in tumors
12/05/2006	US7144989 Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof
12/05/2006	US7144988 Rheumatic diseases; antiarthritic agents; osteoporosis; antiinflammatory agents; complex of protein and immunoglobulin; drug design; computer models
12/05/2006	US7144987 Protein based tumor necrosis factor-receptor variants for the treatment of TNF related disorders
12/05/2006	US7144986 Prevent binding to immunoglobulins; genetic engineering; leukemia, antiproliferative agents, rheumatic diseases
12/05/2006	US7144985 Diagnosis of diabetes using antibody
12/05/2006	US7144983 mutants with multiple neurotrophic specificities; useful in the treatment of neuronal disorders; binds to trkB and other trk-tyrosine kinase receptors
12/05/2006	US7144982 Polypeptides with therapeutic activity and methods of use
12/05/2006	US7144863 Powders of glucagon-like peptide is complexed with a polypeptide of polylysine, polyarginine, polyornithine, protamine, putrescine, spermine, spermidine, and histone; treating diabetes, hyperglycemia, obesity, irritable bowel syndrome, myocardial infarction; drug delivery by inhalation
12/05/2006	US7144862 Orally administered peptides to ameliorate atherosclerosis
12/05/2006	US7144861 Stabilized teriparatide solutions
12/05/2006	US7144859 Somatostatin agonists
12/05/2006	US7144855 Protein complex from ion-exchange chromatography for treatment of bacterial infections
12/05/2006	US7144733 Sensitizing cells to light; obtain cells, transform with vector containing preferential proteins, expose to retinal, illuminate, monitor cell response
12/05/2006	US7144732 Vertebrate embryonic pattern-inducing proteins and uses related thereto
12/05/2006	US7144731 monoclonal antibody immunoreactive with a stem cell factor; hybridoma cell line; can stimulate growth of primitive progenitors including early hematopoietic progenitor cells
12/05/2006	US7144721 Treatment of wounds
12/05/2006	US7144714 recombinantly coexpressing a Dicer protein with an R2D2 protein to form a complex; contacting complex with a double-stranded RNA wherein the complex cleaves the dsRNA into siRNA; Drosophila R2D2 protein; Drosophila Dicer-2 protein; may be coexpressed in insect cells using a baculovirus expression system
12/05/2006	US7144712 Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof
12/05/2006	US7144711 Nucleotide sequences coding G protein coupled-receptor independent activators and inhibitors of the pheromone pathway for treating and preventing cell proliferative and atherosclerotic disorders
12/05/2006	US7144706 Inositol 1,4,5-triphosphate receptors (IP3R); ankyrin-B; for treatment of cardiac hypertrophy, diabetes, pancreas, respiratory system disorders, blood disorders, vision disorders, endocrine inbalance, and/or pain/inflammation
12/05/2006	US7144704 Incubating mammalian cell expressing multidrug resistance gene or P-glycoprotein with immunological reagent specific for a biochemical conformation; evaluating binding; drug screening for anticarcinogenic agents
12/05/2006	US7144698 Postweaning multisystemic wasting syndrome virus from pigs
12/05/2006	US7144697 Synthetic antigen for the detection of antibodies immunoreactive with HIV virus
12/05/2006	US7144581 Anticancer agents
12/05/2006	US7144580 M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever
12/05/2006	US7144579 for producing the vectors and suppressing replication/reducing cytotoxicity of vector genome
12/05/2006	US7144578 Mixture of attenuated genetic engineered virus and carrier
12/05/2006	US7144577 Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy
12/05/2006	US7144576 Modified pertussis toxin
12/05/2006	US7144575 Methods for selectively stimulating proliferation of T cells
12/05/2006	US7144574 For therapy of multiple sclerosis
12/05/2006	US7144569 Mutant gliadin protein whose wild-type sequence can be modified by transglutaminase; fusion protein comprising a non-gliadin sequence; kit comprising antibody to interferon- gamma detects recognition by T-cell
12/05/2006	US7144487 Factor VIII separation
12/05/2006	CA2509508C Tcf mutant
12/05/2006	CA2384929C A novel angiogenesis inhibitor
12/05/2006	CA2246802C A human cytomegalovirus combined antigen and its use
12/05/2006	CA2230912C Alcohol-free wet extraction of gluten dough into gliadin and glutenin
12/05/2006	CA2179183C Interleukin-1 receptor antagonist decreases severity of acute pancreatitis
12/05/2006	CA2151945C Assay and treatment for demyelinating diseases such as multiple sclerosis
12/05/2006	CA2141422C Recombinant equine herpesviruses
11/2006
11/30/2006	WO2006128196A2 Novel substrate for rpn 11 enzymatic activity
11/30/2006	WO2006128176A2 Composite molecules comprising g-csf function
11/30/2006	WO2006128027A1 Functionally active recombinant peptides, methods for producing same and interactions with other peptides
11/30/2006	WO2006127910A2 Glycopegylated erythropoietin formulations
11/30/2006	WO2006127822A2 Scytovirin domain 1 related polypeptides
11/30/2006	WO2006127757A2 Interferon-igg fusion
11/30/2006	WO2006127514A2 Compositions and methods for treating hiv infection with cupredoxin and cytochrome c
11/30/2006	WO2006127507A2 Compounds and methods for labeling oligonucleotides
11/30/2006	WO2006127477A2 Compositions and methods for treating malaria with cupredoxin and cytochrome
11/30/2006	WO2006127284A2 Method of purifying apo-2 ligand/trail using crystallisation in the cold
11/30/2006	WO2006127180A1 A process for preparing (2r,3s)-1,2-epoxy-3-(protected)amino-4-substituted butane and intermediates thereof
11/30/2006	WO2006127048A2 NOVEL pH DEPENDENT ADHESIVE PEPTIDES
11/30/2006	WO2006127020A1 FUNCTIONAL EPITOPES OF STREPTOCOCCUS PNEUMONIAE PsaA ANTIGEN AND USES THEREOF
11/30/2006	WO2006126671A1 Improvement of disease resistance of plant by introducing transcription factor gene
11/30/2006	WO2006126595A1 Three-dimensional structure of functional material
11/30/2006	WO2006126294A1 Transporter gene selective for mugineic acid-iron complex
11/30/2006	WO2006126231A1 Chimeric proteins for measuring atp concentrations in pericellular space and related screening method
11/30/2006	WO2006126209A1 Polypeptides and compositions comprising same and methods of using same for treating cxcr4 associated medical conditions
11/30/2006	WO2006126198A2 Arts c-terminus fragments and mimetics thereof
11/30/2006	WO2006126030A2 Malaria vaccines
11/30/2006	WO2006126029A2 Malaria vaccines
11/30/2006	WO2006126025A2 Cytokine
11/30/2006	WO2006125983A1 Compositions for inducing an immune response against hepatitis b
11/30/2006	WO2006125963A2 Modified leukocyte ig-like receptor family members (lir' s) with increased affinity for class i mhc and their uses in modulating t cell activation
11/30/2006	WO2006125914A2 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections
11/30/2006	WO2006125868A1 Bone morphogenetic proteins containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof
11/30/2006	WO2006125867A1 Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof
11/30/2006	WO2006125866A1 Bone morphogenetic protein 3 and osteogenic devices and pharmaceutical products containing thereof
11/30/2006	WO2006125847A1 Production of and antihypertensive properties of peptides derived from egg white proteins
11/30/2006	WO2006125838A1 Method for the diagnosis and prognosis of demyelinating diseases and for the development of medicaments against demyelinating diseases
11/30/2006	WO2006125632A2 Agonistic antibodies that bind to the tweak receptor fn14 and thereby modulate adiposity-associated phenotypes as well as their use in therapy
11/30/2006	WO2006125490A1 Method for producing virus-type particles containing an active substance
11/30/2006	WO2006125362A1 A culture medium, preparation method thereof and method for culturing nisin
11/30/2006	WO2006112929A3 The hiv gp-41-membrane proximal region arrayed on hepatitis b surface antigen particles as novel antigens
11/30/2006	WO2006107813A3 Site specific incorporation of phosphoserine into polypeptides using phosphoseryl-trna synthetase
11/30/2006	WO2006096345A3 Coagulation and fibrinolytic cascades modulator
11/30/2006	WO2006095029A3 Di-polymer protein conjugates and processes for their preparation
11/30/2006	WO2006088650A3 Method of treating eye injury with local administration of a vegf inhibitor
11/30/2006	WO2006083891A3 Axmi-018, axmi-020, and axmi-021, a family of delta-endotoxin genes and methods for their use
11/30/2006	WO2006075253A3 Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
11/30/2006	WO2006072601A3 THERAPEUTIC USE OF GROWTH FACTORS, NsG29 AND NsG31
11/30/2006	WO2006069403B1 Methods for producing soluble multi-membrane-spanning proteins
11/30/2006	WO2006061406A3 Antimicrobial peptides, polypeptides comprising same, methods for preparing same, genes coding for said peptides, vectors, transformed organisms and compositions containing same
11/30/2006	WO2006046270A3 Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof
11/30/2006	WO2006042745A3 Chemically modified peptide analogs
11/30/2006	WO2006024275A3 Glp-1 and exendin related invention
11/30/2006	WO2006018205A3 Novel essential genes of bacillus licheniformis and improved biotechnical production method based thereon
11/30/2006	WO2005113811A3 Combinatorial selection of phosphorothioate aptamers for tgf-beta
11/30/2006	WO2005108415A3 Membrane associated molecules
11/30/2006	WO2005077042A3 Albumin fusion proteins
11/30/2006	WO2005070965A3 Pharmaceutical compositions containing antagonists to lrp4, lrp8 or megalin for treatment of diseases
11/30/2006	WO2005057166A3 Detection of conformationally altered proteins and prions
11/30/2006	WO2005054286A3 Interleukin-11 fusion proteins
11/30/2006	WO2005021707A3 Severe acute respiratory syndrome dna vaccine compositions and methods of use
11/30/2006	WO2005009379A3 Polypeptides for inducing a protective immune response against staphylococcus aureus
11/30/2006	WO2004047728A3 Compositions and methods for the treatment of immune related diseases
11/30/2006	WO2003016477A3 Insect or83b odorant receptor
11/30/2006	US20060272059 Use of zinc finger transcription factor zpt2-3 to generate plants with increased desiccation tolerance

1 ... 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 ... 2916